Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
804 studies found for:    Open Studies | "Genital Diseases, Female"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Genital Diseases, Female"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Follow-up Strategies for Improved Postoperative Recovery After Benign Hysterectomy
Conditions: Hysterectomy;   Genital Diseases, Female;   Pain
Interventions: Behavioral: Follow-up strategy;   Behavioral: No contact after discharge
2 Not yet recruiting Teleassisted Surgery for Gynecological Disease in Obese Patients - OB-ALFX
Condition: Benign, Premalignant and Malignant Gynecological Disease Confined to the Pelvis
Intervention: Device: Telelap ALF-X
3 Recruiting Effect of Salpingectomy During Conservative Hysterectomy
Conditions: Genital Diseases, Female;   Hysterotomy; Affecting Fetus;   Leiomyomata Uteri;   Adenomyosis, Endometriosis;   Dysfunctional Uterine Bleeding;   Cervical Dysplasia;   Uterine Prolapse
Interventions: Procedure: conservative hysterectomy I;   Procedure: Conservative hysterectomy II
4 Not yet recruiting Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy
Condition: Genital Diseases, Female
Interventions: Device: Guardix-FL;   Device: Interceed
5 Recruiting Prognostic Markers of Gynecologic Cancers
Conditions: Gynecologic Disease;   Gynecologic Cancer
Intervention:
6 Recruiting Biomarkers for Gynecologic Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer;   Benign Gynecological Disease
Intervention:
7 Unknown  Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Conditions: Endometrial Neoplasms;   Uterine Cervical Neoplasms;   Ovarian Neoplasms;   Leiomyoma
Intervention:
8 Not yet recruiting Comparison of Two Ventilation Modes With Laryngeal Mask Airway Guardian
Condition: Gynecologic Disease
Interventions: Procedure: tidal volume;   Procedure: peak airway pressure
9 Not yet recruiting Enhanced Recovery After Surgery: A RCT of Perioperative Management of Gynecologic Patients
Conditions: Laparotomy;   Gynecologic Diseases
Intervention: Other: Enhanced recovery protocol
10 Recruiting Preoperative Warm-up in Gynecologic Surgery
Condition: Gynecologic Disorders
Intervention: Other: Preoperative Warm-Up training
11 Recruiting ADXS11-001 High Dose HPV+ Cervical Cancer
Conditions: Effects of Immunotherapy;   Metastatic/Recurrent Cervical Cancer;   Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Cervical Small Cell Carcinoma;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Intervention: Biological: ADXS11-001
12 Recruiting Mechanism of Incontinence Before and After Genital Prolapse Surgery
Condition: Genital Prolapse
Intervention:
13 Recruiting A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer
Condition: Ovarian Cancer, Pancreatic Cancer
Interventions: Drug: DMCU4064A;   Drug: DMUC4064A
14 Unknown  Diagnostic and Prognostic Value of p16INK4a Expression in Low Grade Squamous Intraepithelial Lesions of the Cervix.
Condition: Cervical Intraepithelial Neoplasia Grade 1 (CIN 1)
Intervention: Procedure: colposcopy
15 Recruiting Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Carcinoma;   Peritoneal Carcinoma
Intervention: Drug: carboplatin and paclitaxel followed by surgery
16 Unknown  Simvastatin and Metformin Therapy in PCOS Women. Prospective Randomised Trial.
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Simvastatin;   Drug: Simvastatin and Metformin;   Drug: Metformin
17 Recruiting Chk1/2 Inhibitor (LY2606368) in Women With BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Non-High Risk Triple Negative Breast Cancer, and High Grade Serous Ovarian Cancer at Low Genetic Risk
Conditions: Ovarian Cancer;   Breast Cancer
Intervention: Drug: LY2606368
18 Not yet recruiting MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer
Conditions: Fallopian Tube Transitional Cell Carcinoma;   Malignant Ovarian Clear Cell Tumor;   Malignant Ovarian Endometrioid Tumor;   Malignant Ovarian Mixed Epithelial Tumor;   Malignant Ovarian Serous Tumor;   Ovarian Transitional Cell Carcinoma;   Primary Peritoneal Serous Adenocarcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Undifferentiated Fallopian Tube Carcinoma;   Undifferentiated Ovarian Carcinoma
Interventions: Biological: Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter;   Drug: Pegylated Liposomal Doxorubicin Hydrochloride;   Drug: Gemcitabine Hydrochloride;   Drug: Topotecan Hydrochloride;   Drug: Paclitaxel;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment
19 Recruiting A Study of Rucaparib as Switch Maintenance Following Platinum-Based Chemotherapy in Patients With Platinum-Sensitive, High-Grade Serous or Endometrioid Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Cancer
Interventions: Drug: Rucaparib;   Drug: Placebo
20 Recruiting Infertility and Endometriosis Cohort
Conditions: Endometriosis;   Infertility
Intervention: Other: live birth date and quality of life assessment

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years